Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer
Clinical trial NCT06818773 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06818773
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2026-12-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.